{"id":46153,"date":"2025-11-08T15:00:27","date_gmt":"2025-11-08T07:00:27","guid":{"rendered":"https:\/\/flcube.com\/?p=46153"},"modified":"2025-11-08T15:00:28","modified_gmt":"2025-11-08T07:00:28","slug":"boehringer-ingelheim-taps-beijing-friendship-hospital-for-mash-trials-expands-china-key-initiative","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46153","title":{"rendered":"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative"},"content":{"rendered":"\n<p><strong>Boehringer Ingelheim<\/strong> announced at the 8th China International Import Expo (CIIE) that it has signed a strategic cooperation agreement with <strong>Beijing Friendship Hospital (BFH)<\/strong> and <strong>Capital Medical University (CMU)<\/strong>. The partnership will target metabolic dysfunction\u2011associated steatohepatitis (MASH) and leverages clinical expertise and R&amp;D capabilities to accelerate the clinical validation of innovative therapeutics in China.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-core-collaboration-details\">Core Collaboration Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Element<\/th><th>Description<\/th><\/tr><\/thead><tbody><tr><td><strong>Partner Institutions<\/strong><\/td><td>Beijing Friendship Hospital &amp; Capital Medical University<\/td><\/tr><tr><td><strong>Key Disease Focus<\/strong><\/td><td>Metabolic Dysfunction\u2011Associated Steatohepatitis (MASH)<\/td><\/tr><tr><td><strong>Program<\/strong><\/td><td>Joint clinical trials, academic exchanges, data\u2013sharing<\/td><\/tr><tr><td><strong>Strategic Context<\/strong><\/td><td>Part of Boehringer\u2019s HOPE (Hospital Partnership Excellence) project and \u201cChina Key\u201d strategy<\/td><\/tr><tr><td><strong>Event<\/strong><\/td><td>Signed during the 8th China International Import Expo (CIIE), Shanghai<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-significance\">Strategic Significance<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical R&amp;D Acceleration<\/strong> \u2013 The collaboration will provide access to a large patient cohort of MASH cases, enabling rapid Phase\u202f2\u20113 study timelines.<\/li>\n\n\n\n<li><strong>Data\u2011Sharing Synergies<\/strong> \u2013 Combining BFH\u2019s extensive electronic health\u2011records network with Boehringer\u2019s clinical trial infrastructure will improve biomarker discovery and real\u2011world evidence generation.<\/li>\n\n\n\n<li><strong>China Key Roll\u2011Out<\/strong> \u2013 By partnering with a flagship public hospital and a leading medical university, Boehringer cements its presence in a high\u2011profile Chinese market and aligns with local regulatory prioritisation for metabolic disease therapeutics.<\/li>\n\n\n\n<li><strong>HOPE Expansion<\/strong> \u2013 This deal extends the HOPE project footprint, reinforcing Boehringer\u2019s hospital\u2011centric partnership model across Asia.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-outlook\">Outlook<\/h2>\n\n\n\n<p>Boehringer expects the joint MASH program to yield data for a potential IND submission in 2026, contingent on regulatory feedback from the China Food and Drug Administration (CFDA). The partnership also positions the company to pursue additional therapeutic areas in future collaborations with BFH and CMU, aligning with broader strategic objectives in the Chinese pharma landscape.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>The information contained herein includes forward\u2011looking statements regarding the strategic partnership, clinical development timelines, and regulatory approval expectations. Actual results may differ materially from those expressed due to market competition, regulatory developments, and other risks.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boehringer Ingelheim announced at the 8th China International Import Expo (CIIE) that it has signed&#8230;<\/p>\n","protected":false},"author":1,"featured_media":46154,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,9],"tags":[106,390],"class_list":["post-46153","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-hospital","tag-academic-conference","tag-boehringer-ingelheim"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Boehringer Ingelheim announced at the 8th China International Import Expo (CIIE) that it has signed a strategic cooperation agreement with Beijing Friendship Hospital (BFH) and Capital Medical University (CMU). The partnership will target metabolic dysfunction\u2011associated steatohepatitis (MASH) and leverages clinical expertise and R&amp;D capabilities to accelerate the clinical validation of innovative therapeutics in China.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46153\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative\" \/>\n<meta property=\"og:description\" content=\"Boehringer Ingelheim announced at the 8th China International Import Expo (CIIE) that it has signed a strategic cooperation agreement with Beijing Friendship Hospital (BFH) and Capital Medical University (CMU). The partnership will target metabolic dysfunction\u2011associated steatohepatitis (MASH) and leverages clinical expertise and R&amp;D capabilities to accelerate the clinical validation of innovative therapeutics in China.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46153\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-08T07:00:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-08T07:00:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0807.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative\",\"datePublished\":\"2025-11-08T07:00:27+00:00\",\"dateModified\":\"2025-11-08T07:00:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153\"},\"wordCount\":330,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0807.webp\",\"keywords\":[\"Academic conference\",\"Boehringer Ingelheim\"],\"articleSection\":[\"Company\",\"Deals\",\"Hospital\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46153#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46153\",\"name\":\"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0807.webp\",\"datePublished\":\"2025-11-08T07:00:27+00:00\",\"dateModified\":\"2025-11-08T07:00:28+00:00\",\"description\":\"Boehringer Ingelheim announced at the 8th China International Import Expo (CIIE) that it has signed a strategic cooperation agreement with Beijing Friendship Hospital (BFH) and Capital Medical University (CMU). The partnership will target metabolic dysfunction\u2011associated steatohepatitis (MASH) and leverages clinical expertise and R&D capabilities to accelerate the clinical validation of innovative therapeutics in China.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46153\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0807.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0807.webp\",\"width\":1080,\"height\":608,\"caption\":\"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46153#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative - Insight, China&#039;s Pharmaceutical Industry","description":"Boehringer Ingelheim announced at the 8th China International Import Expo (CIIE) that it has signed a strategic cooperation agreement with Beijing Friendship Hospital (BFH) and Capital Medical University (CMU). The partnership will target metabolic dysfunction\u2011associated steatohepatitis (MASH) and leverages clinical expertise and R&D capabilities to accelerate the clinical validation of innovative therapeutics in China.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46153","og_locale":"en_US","og_type":"article","og_title":"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative","og_description":"Boehringer Ingelheim announced at the 8th China International Import Expo (CIIE) that it has signed a strategic cooperation agreement with Beijing Friendship Hospital (BFH) and Capital Medical University (CMU). The partnership will target metabolic dysfunction\u2011associated steatohepatitis (MASH) and leverages clinical expertise and R&D capabilities to accelerate the clinical validation of innovative therapeutics in China.","og_url":"https:\/\/flcube.com\/?p=46153","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-08T07:00:27+00:00","article_modified_time":"2025-11-08T07:00:28+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0807.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46153#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46153"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative","datePublished":"2025-11-08T07:00:27+00:00","dateModified":"2025-11-08T07:00:28+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46153"},"wordCount":330,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46153#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0807.webp","keywords":["Academic conference","Boehringer Ingelheim"],"articleSection":["Company","Deals","Hospital"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46153#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46153","url":"https:\/\/flcube.com\/?p=46153","name":"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46153#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46153#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0807.webp","datePublished":"2025-11-08T07:00:27+00:00","dateModified":"2025-11-08T07:00:28+00:00","description":"Boehringer Ingelheim announced at the 8th China International Import Expo (CIIE) that it has signed a strategic cooperation agreement with Beijing Friendship Hospital (BFH) and Capital Medical University (CMU). The partnership will target metabolic dysfunction\u2011associated steatohepatitis (MASH) and leverages clinical expertise and R&D capabilities to accelerate the clinical validation of innovative therapeutics in China.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46153#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46153"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46153#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0807.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0807.webp","width":1080,"height":608,"caption":"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46153#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Boehringer\u202fIngelheim Taps Beijing Friendship Hospital for MASH Trials \u2013 Expands China Key Initiative"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0807.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46153"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46153\/revisions"}],"predecessor-version":[{"id":46155,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46153\/revisions\/46155"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/46154"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}